Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment.

Emmanuelle LüthiManuel DieziNadia DanonJulie DuboisJérôme PasquierBernard BurnandPierre-Yves Rodondi

Published in: BMC complementary medicine and therapies (2021)

The high prevalence of CAM use and the different trends of use during the oncology care pathway and afterward underline the need to increase communication about CAM in the pediatric oncology setting, notably regarding benefits and risks of interaction with oncology treatment.

Keyphrases

palliative care
end stage renal disease
chronic kidney disease
newly diagnosed
healthcare
prognostic factors
human health
patient reported outcomes
climate change
young adults
childhood cancer